Clinician

1-12 of 189 results

  • Epidemiological insights on the gut microbiota in colorectal cancer,  with Dr. Mingyang Song ScD
    Mingyang Song, MBBS, ScD is Associate Professor of Clinical Epidemiology and Nutrition and Faculty Director of Graduate Studies in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, and Associate Professor of Medicine at Harvard Medical School.

  • Molecular mechanisms of colorectal cancer development, with Prof. Alberto Martin PhD
    Prof. Alberto Martin from University of Toronto (Canada), speaks about the molecular mechanisms by which certain bacteria – namely, pks+ E. coli – influence colorectal cancer development. pks+ E.

  • Better study design for better probiotic science
    ILSI Europe brought together academic researchers and scientists from industry to identify the aspects of probiotic research that are not covered by existing methodological guidance. The result was PRODARE, a consensus framework designed to support better study design, conduct, and reporting in probiotic research. 

  • Gut microbiome signatures of colorectal cancer, with Dr. Georg Zeller PhD
    Dr. Georg Zeller PhD from Leiden University Medical Center (the Netherlands), speaks about gut microbiome signatures of colorectal cancer across global populations.

  • Biofilms and specific bacteria in colorectal cancer development, with Prof. Cynthia L. Sears, MD
    Prof. Cynthia L. Sears, MD from the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health (USA), speaks about both biofilms and specific gut microorganisms that may contribute to colorectal cancer development.

  • The early life gut microbiota in the developmental origins of health & disease, with Dr. Anne Salonen PhD
    Dr. Anne Salonen PhD from University of Helsinki (Finland) speaks about her studies on the gut microbiota in early life and how it relates to health and disease.

  • Factors affecting infant gut microbiota development, with Prof. Christopher Stewart PhD
    Prof. Christopher Stewart PhD from Newcastle University (UK), speaks about the factors affecting gut microbiota development in both non-preterm and preterm infants.

  • Probiotics with antibiotics: Let’s follow the evidence
    In this blog, experts address a media article on probiotics with antibiotics and advocate for using evidence instead of weak but plausible-sounding recommendations.
  • scientific posters displayed in an atrium, with people looking and pointing at the posters

    ISAPP welcomes participation in upcoming one-day scientific symposium in Tokyo
    To help meet the goals of accelerating global scientific advancement and showcasing innovative biotics research, ISAPP will hold a scientific symposium on October 6, 2026 in Tokyo, Japan in conjunction with its annual meeting.

  • A mechanism linking the newborn skin microbiota to neurodevelopment, with Prof. Rihua Xie and Dr. Yuhang Zhang
    Prof. Rihua Xie and Dr. Yuhang Zhang speak about vaginal microbiota transfer (VMT) and how it may affect neurodevelopment in newborn infants born by Cesarean section.
  • Gut microbiota development in preterm and non-preterm infants

    Gut microbiota development in preterm and non-preterm infants, with Dr. Marie-Claire Arrieta PhD
    Dr. Marie-Claire Arrieta PhD from the University of Calgary (Canada), speaks about development of the early life gut microbiome, both in preterm and non-preterm infants.
  • Doctor looking at paper, with hand resting on face in confused manner

    When probiotics guidelines differ: a practical guide for clinicians and researchers
    Panel members from the ISAPP meeting led the publication of an Editorial in Gut Microbes on how to navigate guidelines from trusted professional societies when they produce differing conclusions about the use of probiotics for gastrointestinal disorders.